[VRTX] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
28-Apr-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- 652.03%
YoY- 695.12%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 1,515,107 858,435 640,799 714,718 398,080 138,509 118,451 52.86%
PBT 657,534 320,165 214,642 253,533 -30,617 -198,405 -231,654 -
Tax 54,781 51,534 -12,659 3,985 5,485 299 803 102.01%
NP 602,753 268,631 210,263 247,756 -41,631 -198,606 -232,457 -
Tax Rate -8.33% -16.10% 5.90% -1.57% - - - -
Total Cost 912,354 589,804 430,536 466,962 439,711 337,115 350,908 17.24%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 39.78 31.29 32.81 34.66 -10.46 -143.39 -196.25 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS 2.32 1.05 0.83 1.01 -0.17 -0.83 -1.00 -
EPS Diluted 2.29 1.03 0.81 0.99 -0.17 -0.83 -1.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.